These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20874016)

  • 21. Systemic anti-tumor activity of liposomal glucocorticoids.
    Park K
    J Control Release; 2011 Apr; 151(1):1. PubMed ID: 21440020
    [No Abstract]   [Full Text] [Related]  

  • 22. Nanotherapeutic shows great potential for increased killing of cancer cells.
    Nanomedicine (Lond); 2011 Feb; 6(2):309-10. PubMed ID: 21504095
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
    Oku N; Namba Y
    Methods Enzymol; 2005; 391():145-62. PubMed ID: 15721379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendrimers in oncology: an expanding horizon.
    Tekade RK; Kumar PV; Jain NK
    Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
    [No Abstract]   [Full Text] [Related]  

  • 25. Sterically stabilized liposomes in cancer therapy and gene delivery.
    Lasic DD; Vallner JJ; Working PK
    Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor priming enhances delivery and efficacy of nanomedicines.
    Lu D; Wientjes MG; Lu Z; Au JL
    J Pharmacol Exp Ther; 2007 Jul; 322(1):80-8. PubMed ID: 17420296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is nanomedicine still promising?
    Peiris PM; Karathanasis E
    Oncotarget; 2011 Jun; 2(6):430-2. PubMed ID: 21677362
    [No Abstract]   [Full Text] [Related]  

  • 29. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3.
    Collins T
    IDrugs; 2007 Dec; 10(12):840-3. PubMed ID: 18041675
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
    Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
    Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
    [No Abstract]   [Full Text] [Related]  

  • 31. Liposomes for drug delivery to mitochondria.
    Boddapati SV; D'Souza GG; Weissig V
    Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liposomes as drug vehicles in the treatment of neoplasms].
    Jamrozik-Kruk Z; Zmudziński J; Laskawiec G
    Pol Tyg Lek; 1987 Apr; 42(15):427-30. PubMed ID: 3615270
    [No Abstract]   [Full Text] [Related]  

  • 34. Nanotheraputics.
    Ravi Kumar MN; Blanco-Prieto MJ; Waterhouse DN
    Cancer Lett; 2013 Jul; 334(2):155-6. PubMed ID: 23523611
    [No Abstract]   [Full Text] [Related]  

  • 35. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of targeting thermosensitive liposomes for tumor treatment].
    Chen J
    Yao Xue Xue Bao; 2011 May; 46(5):502-6. PubMed ID: 21800535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour-selective drug delivery via folate receptor-targeted liposomes.
    Pan X; Lee RJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
    Maruyama K
    Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.